<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01378325</url>
  </required_header>
  <id_info>
    <org_study_id>ANES.SS.10</org_study_id>
    <nct_id>NCT01378325</nct_id>
  </id_info>
  <brief_title>Variable Rate Phenylephrine Infusion for Prevention of Spinal-induced Hypotension for Cesarean Delivery</brief_title>
  <official_title>Crystalloid Coload Combined With Variable Rate Phenylephrine Infusion for Prevention of Hypotension During Spinal Anesthesia for Elective Cesarean Delivery vs Crystalloid Coload Alone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American University of Beirut Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American University of Beirut Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rapid administration of crystalloid immediately after induction of spinal anesthesia (coload)
      to be more effective in terms of managing hypotension as compared to administering
      crystalloid before spinal anesthesia (preload).

      Phenylehrine infusion is a safe and effective way to reduce incidence and frequency of
      hypotension during SA for cesarean delivery. Hypotension was virtually eliminated by use of
      high-dose prophylactic phenylephrine infusion at a rate of 100 µg/min and rapid crystalloid
      coload up to two liters (administration at the time of SA). However, incidence of reactive
      hypertension was frequent up to 47% with decrease in maternal heart rate (HR). This may raise
      concern in patients in whom increase of blood pressure may be detrimental, like chronic
      hypertension and in the presence of a compromised uteroplacental blood flow. A recent study
      found that infusing phenylephrine at a fixed rate of 75 and 100 ug/min is associated with
      more episodes of hypertension than placebo or the lower infusion rates of 25 and 50 ug/min
      respectively. However, there was no reduction in the number of physician interventions
      (phenylephrine boluses and stopping the infusion) needed to maintain maternal systolic blood
      pressure within 20% of baseline among all groups. Prophylactic fixed rate infusions may have
      limited application in clinical practice, and a variable rate (i.e. modifying the rate
      according to hemodynamics) has been advocated. The bolus administration of phenylephrine to
      treat hypotension is still commonly used, but requests multiple interventions from the
      anesthesiologists and is time consuming.

      Eighty patients scheduled for cesarean delivery under spinal anesthesia will be assigned to
      one of two groups. Immediately after spinal injection, rapid crystalloid colaod of lactated
      Ringer of 15 mL/kg over a period of 10-15 min will be initiated. Patients in Group I will
      receive infusion of normal saline (placebo) and patients in group II variable infusion rate
      of phenylephrine started at 0.75 ug/kg (close to the dose of 50 ug/min recommended for fixed
      infusion rate). The number of interventions needed to maintain maternal systolic blood
      pressure within 20% of baseline, hemodynamic performance, intraoperative nausea and vomiting,
      and umbilical cord blood gases will be compared between the two groups.

      We will define a reliable and safe method to ensure maternal hemodynamic stability during
      spinal anesthesia for cesarean delivery with the least physician interference.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Physician Interventions Needed to Maintain Maternal Blood Pressure After Spinal Anesthesia Within 20% of Baseline and to Treat Bradycardia During Cesarean Delivery.</measure>
    <time_frame>Patients will be followed up throughout the Cesarean delivery (average of 1.5 hours).</time_frame>
    <description>Physician interventions are triggered by hemodynamic changes more than 20% of baseline. The intervention can be one or more of the following:
stopping the phenylephrine infusion
changing the rate of phenylephrine infusion
rescue intravenous bolus of phenylephrine (100 µg) for hypotension
rescue intravenous bolus of atropine (0.4 mg) for bradycardia</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Anesthetic Complication Spinal</condition>
  <arm_group>
    <arm_group_label>Phenylephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PHenylephrine infusion started at 0.75 microgram per kg per mL started at spinal injection till delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Prophylactic variable rate of saline infusion where we adjusted the pump at a starting rate of 0.75 µg/kg/min, equivalent to 0.0075 mL/kg/min of saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine</intervention_name>
    <description>Prophylactic variable rate of phenylephrine infusion started at 0.75 µg/kg/min vs saline</description>
    <arm_group_label>Phenylephrine</arm_group_label>
    <other_name>Neosynephrine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>Prophylactic variable rate of saline infusion where we adjusted the pump at a starting rate of 0.75 µg/kg/min, equivalent to 0.0075 mL/kg/min of saline</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parturients beyond 37 weeks gestation

          -  ASA І or ІІ

        Exclusion Criteria:

          -  pregnancy-induced hypertension

          -  chronic hypertension

          -  multiple pregnancy

          -  fetal compromise

          -  diabetes mellitus

          -  polyhydramnios

          -  body weight &gt;100 kg

          -  major systemic disease

          -  anemia (hemoglobin concentration&lt;10 g/dl)

          -  clotting diathesis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2011</study_first_submitted>
  <study_first_submitted_qc>June 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2011</study_first_posted>
  <results_first_submitted>July 2, 2014</results_first_submitted>
  <results_first_submitted_qc>August 11, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 26, 2014</results_first_posted>
  <last_update_submitted>August 11, 2014</last_update_submitted>
  <last_update_submitted_qc>August 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>American University of Beirut Medical Center</investigator_affiliation>
    <investigator_full_name>Sahar Sayyid</investigator_full_name>
    <investigator_title>anesthesia</investigator_title>
  </responsible_party>
  <keyword>spinal</keyword>
  <keyword>cesarean delivery</keyword>
  <keyword>phenylephrine</keyword>
  <keyword>hypotension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Phenylephrine</title>
          <description>PHenylephrine infusion started at 0.75 microgram per kg per mL started at spinal injection till delivery
Phenylephrine: Prophylactic variable rate of phenylephrine infusion started at 0.75 µg/kg/min vs saline</description>
        </group>
        <group group_id="P2">
          <title>Saline</title>
          <description>crystalloid coload with lactated Ringer solution combined with prophylactic variable rate of saline infusion where we adjusted the pump at a starting rate of 0.75 µg/kg/min, equivalent to 0.0075 mL/kg/min of saline</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>with β of 0.2 and α of 0.05 and two-sided test for comparing two means (http://www.stat.ubc.ca/~rollin/stats/ssize/n2.html), the calculated number of patients was 37 in each group.</population>
      <group_list>
        <group group_id="B1">
          <title>Saline</title>
          <description>Prophylactic variable rate of saline infusion where we adjusted the pump at a starting rate of 0.75 µg/kg/min, equivalent to 0.0075 mL/kg/min of saline</description>
        </group>
        <group group_id="B2">
          <title>Phenylephrine</title>
          <description>PHenylephrine infusion started at 0.75 microgram per kg per mL started at spinal injection till delivery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="79"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.5" spread="5"/>
                    <measurement group_id="B2" value="32.5" spread="5"/>
                    <measurement group_id="B3" value="33" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <description>Gender, female</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Number of Female Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Physician Interventions Needed to Maintain Maternal Blood Pressure After Spinal Anesthesia Within 20% of Baseline and to Treat Bradycardia During Cesarean Delivery.</title>
        <description>Physician interventions are triggered by hemodynamic changes more than 20% of baseline. The intervention can be one or more of the following:
stopping the phenylephrine infusion
changing the rate of phenylephrine infusion
rescue intravenous bolus of phenylephrine (100 µg) for hypotension
rescue intravenous bolus of atropine (0.4 mg) for bradycardia</description>
        <time_frame>Patients will be followed up throughout the Cesarean delivery (average of 1.5 hours).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>PHenylephrine infusion started at 0.75 microgram per kg per mL started at spinal injection till delivery
Phenylephrine: Prophylactic variable rate of phenylephrine infusion started at 0.75 µg/kg/min vs saline</description>
          </group>
          <group group_id="O2">
            <title>Saline</title>
            <description>crystalloid coload with lactated Ringer solution combined with prophylactic variable rate of saline infusion where we adjusted the pump at a starting rate of 0.75 µg/kg/min, equivalent to 0.0075 mL/kg/min of saline</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Physician Interventions Needed to Maintain Maternal Blood Pressure After Spinal Anesthesia Within 20% of Baseline and to Treat Bradycardia During Cesarean Delivery.</title>
          <description>Physician interventions are triggered by hemodynamic changes more than 20% of baseline. The intervention can be one or more of the following:
stopping the phenylephrine infusion
changing the rate of phenylephrine infusion
rescue intravenous bolus of phenylephrine (100 µg) for hypotension
rescue intravenous bolus of atropine (0.4 mg) for bradycardia</description>
          <units>number of interventions</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="6"/>
                    <measurement group_id="O2" value="3" lower_limit="0" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Saline</title>
          <description>Prophylactic variable rate of saline infusion where we adjusted the pump at a starting rate of 0.75 µg/kg/min, equivalent to 0.0075 mL/kg/min of saline</description>
        </group>
        <group group_id="E2">
          <title>Phenylephrine</title>
          <description>Phenylephrine infusion started at 0.75 microgram per kg per mL started at spinal injection till delivery</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sahar Siddik-Sayyid</name_or_title>
      <organization>AUBMC</organization>
      <phone>9611350000 ext 6380</phone>
      <email>ss01@aub.edu.lb</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

